Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001387131-11-001390
Filing Date
2011-07-29
Accepted
2011-07-29 16:58:54
Documents
5
Period of Report
2011-03-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO ANNUAL REPORT adamis-10ka_072711.htm 10-K/A 371060
2 302 CERTIFICATION OF CEO ex-31_1.htm EX-31.1 11935
3 302 CERTIFICAITON OF CFO ex-31_2.htm EX-31.2 12411
4 906 CERTIFICATION OF CEO ex-32_1.htm EX-32.1 7047
5 906 CERTIFICATION OF CFO ex-32_2.htm EX-32.2 7690
  Complete submission text file 0001387131-11-001390.txt   411271
Mailing Address 2658 DEL MAR HEIGHTS RD #555 DEL MAR CA 92014
Business Address 2658 DEL MAR HEIGHTS RD #555 DEL MAR CA 92014 (858) 401-3984
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

EIN.: 820429727 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-K/A | Act: 34 | File No.: 000-26372 | Film No.: 11998074
SIC: 2834 Pharmaceutical Preparations